Inventor
Luigi Naldini
Inventor
Milan, IT
Overview
Patents· 26 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C12Nprimary
C12NMicroorganisms or enzymes35%
A61KPreparations for medical, dental or toiletry purposes27%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations16%
C07KPeptides16%
A01KAnimal husbandry1%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms1%
G01NInvestigating or analysing materials by determining their chemical or physical properties1%
Y02ATechnologies for adaptation to climate change1%
PatentTitleYear
10,918,668Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases202110,912,824Vector production202110,617,721Methods for genetic modification of stem cells202010,287,579Gene vector201910,155,011Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases201810,117,899Delivery methods and compositions for nuclease-mediated genome engineering in hematopoietic stem cells201810,000,757Gene vector20189,951,328Gene vector20189,938,540Gene vector for inducing transgene-specific immune tolerance20189,937,207Targeted disruption of T cell receptor genes using talens20189,556,438'Gene vector'20179,493,827'Determination of in vivo DNA double-strand break localization and application thereof'20168,956,828'Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases'20158,936,936'Methods and compositions for targeted integration'20158,846,385'Method and means for producing high titer, safe recombinant lentivirus vectors'20148,652,837'Method and means for producing high titer, safe, recombinant lentivirus vectors'20148,501,464'Lentiviral vectors carrying synthetic bi-directional promoters and uses thereof'20137,833,789'Monocyte cell'20107,250,299'Method and means for producing high titer, safe, recombinant lentivirus vectors'20077,083,981'Method and means for producing high titer, safe, recombinant lentivirus vectors'20066,924,144'Method and means for producing high titer, safe, recombinant lentivirus vectors'20056,797,512'Selection system for generating efficient packaging cells for lentiviral vectors'20046,428,953'Method and means for producing high titer, safe, recombinant lentivirus vectors'20026,165,782'Method and means for producing high titer, safe, recombinant lentivirus vectors'20006,013,516'Vector and method of use for nucleic acid delivery to non-dividing cells'20005,994,136'Method and means for producing high titer, safe, recombinant lentivirus vectors'1999Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1999–2007Patents assigned to CELL GENESYS INC (7)· patent assignee history
1999–2014Based in San Carlos, CA, US· patent location history
2000Based in Del Mar, CA, US· patent location history
2004–2007Based in Turin, IT· patent location history
2010–2021Patents assigned to FOND TELETHON (9)· patent assignee history
2010–2021Based in Milan, IT· patent location history
2013–2021Patents assigned to OSPEDALE SAN RAFFAELE SRL (14)· patent assignee history
2013–2019Patents assigned to NALDINI LUIGI (9)· patent assignee history
2015–2018Patents assigned to SANGAMO BIOSCIENCES INC (5)· patent assignee history
2015Based in Pioltello, IT· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| OSPEDALE SAN RAFFAELE SRL | 14 | 2013–2021 |
| FOND TELETHON | 9 | 2010–2021 |
| NALDINI LUIGIself | 9 | 2013–2019 |
| CELL GENESYS INC | 7 | 1999–2007 |
| SANGAMO BIOSCIENCES INC | 5 | 2015–2018 |
Locations
| Location | Patents | Span |
|---|---|---|
| Milan, IT | 14 | 2010–2021 |
| San Carlos, California, US | 7 | 1999–2014 |
| Pioltello, IT | 2 | 2015 |
| Turin, IT | 2 | 2004–2007 |
| Del Mar, California, US | 1 | 2000 |